OCUL

Ocular Therapeutix develops eye medicines using a technology that slowly dissolves inside the eye over time. The company sells DEXTENZA, a small insert that reduces inflammation and pain after eye surgery and is also used for allergic itching of the eyes. The company is testing other eye medicines in clinical trials to treat serious conditions like age-related vision loss and glaucoma, a disease that damages the optic nerve.